
Analysts’ Updated EPS Estimates for January 21st (ABM, ACRS, AIRG, AMH, AMZE, APA, CASY, CCS, CNX, COGT)
Analysts’ updated eps estimates for Wednesday, January 21st: ABM Industries (NYSE:ABM) had its hold rating reissued by analysts at Truist Financial Corporation. The firm currently has a $47.00 target price on the stock, down from their previous target price of $58.00. Aclaris Therapeutics (NASDAQ:ACRS) had its buy rating reiterated by analysts at HC Wainwright. They [...]







